[B039] 药物交易信息

get
https://connect.zhihuiya.com/synapse/drug-deal
在体验中心中试用

获取药物交易信息，包括转让方、受让方、交易时间、药物等

请求参数

此 API 接口支持的参数列表

名称类型示例描述
deal_id
必填
string284929245a22a8a9e2ed5ee82ae52250
药物交易ID，通过[B045]药物交易检索接口获取

响应结构

API 响应数据的结构说明

字段名类型示例描述
data
object-
响应数据
drug
array[ { "drug_id": "81364d1ace044fdc8af8f60026eb2c7b", "display_name": [ { "lang": "EN", "name": "Ciltacabtagene autoleucel" }, { "lang": "CN", "name": "西达基奥仑赛" } ] } ]
药物，引用“CommonDrug”
drug_id
stringe82b83b42eba4e5ea3f26f8e06081a5a
药物ID
display_name
array[ { "lang": "EN", "name": "Ranibizumab (Genentech)" }, { "lang": "CN", "name": "雷珠单抗" } ]
药物名称，引用“CommonName”
lang
stringEN
语言
name
stringRanibizumab (Genentech)
药物、靶点、机构、适应症、国家/地区、字典、作用机制 名称
target
array[ { "target_id": "e49efee164e537c2a4ba9cec109e0adb", "short_name": [ { "lang": "EN", "name": "BCMA" } ], "display_name": [ { "lang": "EN", "name": "B-cell maturation protein" }, { "lang": "CN", "name": "B细胞成熟蛋白" } ] } ]
靶点，引用“CommonTarget”
target_id
string1c2067e5ab054a8995f73efcfcf56207
靶点ID
short_name
array[ { "lang": "EN", "name": "VEGF" } ]
靶点简称，引用“CommonName”
display_name
array[ { "lang": "EN", "name": "Vascular endothelial growth factor" }, { "lang": "CN", "name": "血管内皮生长因子" } ]
靶点全称，引用“CommonName”
deal_id
string284929245a22a8a9e2ed5ee82ae52250
药物交易ID
partner
array[ { "display_name": [ { "lang": "EN", "name": "Janssen Biotech, Inc." }, { "lang": "CN", "name": "森托克奧素生物技術產品有限合夥事業" } ], "organization_id": "ee3f62ab873c539d75e06f49cc09d7fc" } ]
受让方，引用“CommonOrganization”
display_name
array[ { "lang": "EN", "name": "Roche Holding AG" }, { "lang": "CN", "name": "罗氏" } ]
机构名称，引用“CommonName”
organization_id
string87bfaf037f8e60c9e25595cd98bb27e4
机构ID
deal_time
integer<int64>1513814400000
交易时间
deal_type
array[ { "display_name": [ { "lang": "EN", "name": "License" }, { "lang": "CN", "name": "许可" } ], "normalized_id": "c6bb6fa84d924b0cabd8f5dd2af17708" } ]
交易类型，引用“CommonDictionary”
display_name
array[ { "lang": "EN", "name": "Autologous CAR-T" }, { "lang": "CN", "name": "自体CAR-T" } ]
字典名称
normalized_id
string2fbfdb3e92d942c48cbb0adb79f23526
字典ID
drug_type
array[ { "display_name": [ { "lang": "EN", "name": "Autologous CAR-T" }, { "lang": "CN", "name": "自体CAR-T" } ], "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526" } ]
药物类型，引用“CommonDictionary”
principle
array[ { "display_name": [ { "lang": "EN", "name": "Legend Biotech USA, Inc." } ], "organization_id": "336e7d3b6f91616c632bc60c40a434de" }, { "display_name": [ { "lang": "EN", "name": "Nanjing Legend Biotech Co., Ltd." }, { "lang": "CN", "name": "南京传奇生物科技有限公司" } ], "organization_id": "a22fd154855c015ed283545df379f0de" } ]
转让方，引用“CommonOrganization”
deal_title
stringJanssen Enters Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer Therapy
交易名称
source_url
stringhttps://pipelinereview.com/index.php/2017122266940/More-News/Janssen-Enters-Worldwide-Collaboration-and-License-Agreement-with-Chinese-Company-Legend-Biotech-to-Develop-Investigational-CAR-T-Anti-Cancer-Therapy.html
新闻链接
deal_status
object{ "display_name": [ { "lang": "EN", "name": "Active" }, { "lang": "CN", "name": "进行中" } ], "normalized_id": "4403ccfb0e0d46b7bc86e3d14b8259e0" }
交易状态，引用“CommonDictionary”
deal_total_value
object{ "value": "Undisclosed" }
总金额，引用“MoneyItem”
unit
stringmillion dollar
交易单位, 枚举值：million dollar。金额未披漏时，返回为空。
value
string5000
交易金额，未披漏则返回“Undisclosed”
territory_excluded
array[ { "country_id": "676de5ba-893a-36bb-8683-c93306aaf769", "alpha2_code": "JP", "display_name": [ { "lang": "EN", "name": "Japan" }, { "lang": "CN", "name": "日本" } ] } ]
权益地区（不包含），引用“CommonCountry”
country_id
string676de5ba-893a-36bb-8683-c93306aaf769
国家地区ID
alpha2_code
stringUS
国家编码
display_name
array[ { "lang": "EN", "name": "United States" }, { "lang": "CN", "name": "美国" } ]
国家地区名称
territory_included
array[ { "country_id": "4cc6684d-f7b4-392b-9dec-6fce3264fac8", "display_name": [ { "lang": "EN", "name": "Global" }, { "lang": "CN", "name": "全球" } ] } ]
权益地区（包含），引用“CommonCountry”
deal_upfront_payment
object{ "unit": "million dollars", "value": "350.00" }
首付款，引用“MoneyItem”
deal_milestone_payment
object{ "value": "Undisclosed" }
里程碑，引用“MoneyItem”
status
必填
booleanfalse
状态
error_msg
stringThe request parameter format is incorrect！
错误信息
error_code
必填
integer0
错误代码

成功响应示例

成功调用 API 的响应示例

JSON 
{
  "data": {
    "drug": [
      {
        "drug_id": "e82b83b42eba4e5ea3f26f8e06081a5a",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "target": [
      {
        "target_id": "1c2067e5ab054a8995f73efcfcf56207",
        "short_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "deal_id": "284929245a22a8a9e2ed5ee82ae52250",
    "partner": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
      }
    ],
    "deal_time": 1513814400000,
    "deal_type": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
      }
    ],
    "drug_type": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
      }
    ],
    "principle": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "organization_id": "87bfaf037f8e60c9e25595cd98bb27e4"
      }
    ],
    "deal_title": "Janssen Enters Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer Therapy",
    "source_url": "https://pipelinereview.com/index.php/2017122266940/More-News/Janssen-Enters-Worldwide-Collaboration-and-License-Agreement-with-Chinese-Company-Legend-Biotech-to-Develop-Investigational-CAR-T-Anti-Cancer-Therapy.html",
    "deal_status": {
      "display_name": [
        {
          "lang": "EN",
          "name": "Ranibizumab (Genentech)"
        }
      ],
      "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
    },
    "deal_total_value": {
      "unit": "million dollar",
      "value": 5000
    },
    "territory_excluded": [
      {
        "country_id": "676de5ba-893a-36bb-8683-c93306aaf769",
        "alpha2_code": "US",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "territory_included": [
      {
        "country_id": "676de5ba-893a-36bb-8683-c93306aaf769",
        "alpha2_code": "US",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "deal_upfront_payment": {
      "unit": "million dollar",
      "value": 5000
    },
    "deal_milestone_payment": {
      "unit": "million dollar",
      "value": 5000
    }
  },
  "status": true,
  "error_code": 0
}

错误码

此接口可能返回的错误码列表

业务错误码

错误码描述
68300004请求参数异常!
68300005查询Api失败!
68300006解析基本存取错误!
68300007存在错误的请求!
68300008服务中断异常，请稍后再试!
68300010文件不符合上传规范!

平台错误码

错误码描述
67200001API整体限流错误!
67200002用户调用请求限流限制错误!
67200003申请token的key和secret不正确或者状态错误!
67200004无权限或该接口的套餐已超过系统设置的上限!
67200005账户余额不足，调用失败!
67200006客户端已过期，调用失败!
67200007超过调用额度，调用失败!

HTTP 状态码

状态码描述
0请求成功
401Unauthorized
403Forbidden
404Not Found

性能指标

此接口的预期性能特征

正常响应时间

5000 ms

最大响应时间

10000 ms